Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Pilot Study to Evaluate the Safety and Performance of the MEX-CD1 Medical Device in Acute on Chronic Liver Failure (ACLF)

NCT06340269 is registered in ClinicalTrials.gov with Mexbrain as lead sponsor.

NCT NCT06340269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06340269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Pilot Study to Evaluate the Safety and Performance of the MEX-CD1 Medical Device in Acute on Chronic Liver Failure (ACLF)
Lead sponsor
Mexbrain
Phase
Not applicable
Overall status
Completed
Start date
June 21, 2024
Completion date
October 23, 2025
Enrollment
11 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute on chronic liver failure, multiple organ failure